ArticleJCI insight2026

Consideration of spatial companion biomarkers for targeted therapeutics in cancer: depatuxizumab mafodotin in glioblastoma.

Rimas V Lukas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.